Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(4):295-297; doi:10.1093/jnci/92.4.295
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gottlieb, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gottlieb, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 4, 295-297, February 16, 2000
© 2000 Oxford University Press

NEWS

San Antonio Breast Cancer Symposium Explores DCIS "Battleground"

Nicole Gottlieb

Management of diagnoses such as ductal carcinoma in situ is today’s breast cancer battleground, Bernard Fisher, M.D., scientific director of the National Surgical Adjuvant Breast and Bowel Project, told an audience at the 22nd Annual San Antonio Breast Cancer Symposium.



View larger version (152K):
[in this window]
[in a new window]
  		Dr. Bernard Fisher

 
The need for solutions is great because the widespread adoption of screening mammography in the United States has resulted in a substantial increase in the number of women diagnosed with DCIS. In 1983, nearly 5,000 women were diagnosed with DCIS, according to Virginia Ernster, Ph.D., and her colleagues at the University of California at San Francisco School of Medicine. In 1997, more than 36,000 new cases of DCIS were diagnosed in the United . . . [Full Text of this Article]

A New Standard Treatment?

Adding Tamoxifen

Radiation: Yes or No?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
J. Clin. Oncol., November 20, 2007; 25(33): 5287 - 5312.
[Abstract] [Full Text] [PDF]